Free Trial
NASDAQ:CELU

Celularity (CELU) Stock Price, News & Analysis

Celularity logo
$3.85 +0.05 (+1.32%)
Closing price 04:00 PM Eastern
Extended Trading
$3.85 0.00 (0.00%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Celularity Stock (NASDAQ:CELU)

Key Stats

Today's Range
$3.75
$3.99
50-Day Range
$1.76
$4.15
52-Week Range
$1.00
$5.22
Volume
55,565 shs
Average Volume
66,259 shs
Market Capitalization
$92.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
N/A

Company Overview

Celularity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

CELU MarketRank™: 

Celularity scored higher than 13% of companies evaluated by MarketBeat, and ranked 904th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Percentage of Shares Shorted

    11.50% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Celularity has recently increased by 8.39%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Celularity does not currently pay a dividend.

  • Dividend Growth

    Celularity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.50% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Celularity has recently increased by 8.39%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Celularity has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Celularity this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Celularity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.10% of the stock of Celularity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.02% of the stock of Celularity is held by institutions.

  • Read more about Celularity's insider trading history.
Receive CELU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CELU Stock News Headlines

Celularity (NASDAQ:CELU) Trading 1.3% Higher Following Analyst Upgrade
Celularity (NASDAQ:CELU) Upgraded at Wall Street Zen
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Celularity Receives Nasdaq Notice Regarding Form 10-Q
Celularity (NASDAQ:CELU) Coverage Initiated at WBB Securities
BRIEF-Celularity Completes Major Balance Sheet Restructuring
See More Headlines

CELU Stock Analysis - Frequently Asked Questions

Celularity's stock was trading at $2.08 on January 1st, 2025. Since then, CELU stock has increased by 85.1% and is now trading at $3.85.

Celularity, Inc. (NASDAQ:CELU) announced its earnings results on Thursday, May, 8th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.50) by $0.91. The business earned $18.13 million during the quarter, compared to the consensus estimate of $5.20 million. Celularity had a negative trailing twelve-month return on equity of 271.88% and a negative net margin of 106.77%.

Shares of Celularity reverse split on the morning of Thursday, February 29th 2024.The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional shareholders of Celularity include Valmark Advisers Inc. (0.21%), Bank of America Corp DE (0.16%), XTX Topco Ltd (0.09%) and Simplex Trading LLC. Insiders that own company stock include Kok Thay Lim and Robert J Hariri.
View institutional ownership trends
.

Shares of CELU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celularity investors own include NVIDIA (NVDA), Meta Platforms (META), Lovesac (LOVE), MannKind (MNKD), PayPal (PYPL), Tesla (TSLA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/08/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELU
CIK
1752828
Fax
N/A
Employees
220
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+55.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.89 million
Net Margins
-106.77%
Pretax Margin
-106.77%
Return on Equity
-271.88%
Return on Assets
-42.82%

Debt

Debt-to-Equity Ratio
4.07
Current Ratio
0.38
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$54.22 million
Price / Sales
1.70
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
10.41

Miscellaneous

Outstanding Shares
23,950,000
Free Float
18,656,000
Market Cap
$92.21 million
Optionable
Optionable
Beta
0.79

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CELU) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners